Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Wilex (Germany) | Researchclopedia

Back to institutions

Wilex (Germany)

Munichcompany

65

Works

5,996

Citations

51

h-index

Top Research Topics

Protease and Inhibitor Mechanisms Peptidase Inhibition and Analysis Blood Coagulation and Thrombosis Mechanisms

Top Researchers

Robert J. Motzer Memorial Sloan Kettering Cancer Center

1,589 works123,609 citationsh-index: 148

Recent Research

Physical characterization of aqueous potassium formate and bicarbonate solutions for hydrogen storage Applications, including determination of degree of hydrogenation

Volkan Turan,Jonas Massa,et al.

20250 citations

Renal cell carcinoma treatment

Monoclonal and Polyclonal Antibodies Research

Coagulation, Bradykinin, Polyphosphates, and Angioedema

Renal and related cancers

Cancer Genomics and Diagnostics

Cancer Treatment and Pharmacology

Enzyme function and inhibition

Lymphoma Diagnosis and Treatment

Glycosylation and Glycoproteins Research

Nadia Harbeck Deutsches Archäologisches Institut, Zentrale

2,055 works85,117 citationsh-index: 131

Robert Huber Medizinisches Laserzentrum Lübeck (Germany)

746 works81,892 citationsh-index: 147

John A. Foekens European Bioinformatics Institute

643 works65,696 citationsh-index: 107

Steven M. Larson Memorial Sloan Kettering Cancer Center

1,153 works60,955 citationsh-index: 133

Horst Kessler Institute for Advanced Study

1,025 works53,363 citationsh-index: 111

Global Solar Link (GSL) – 100 % Renewable Power to the World

Ralf Leutz,Johannes Pohl

20240 citations

Pharmacokinetics of JNJ‐73763989 and JNJ‐56136379 (Bersacapavir) in Participants With Moderate Hepatic Impairment

Thomas N. Kakuda,Atef Halabi,et al.

20236 citations

Effect of Severe Renal Impairment on Pharmacokinetics, Safety, and Tolerability of ACT‐1014‐6470, a Novel Oral Complement Factor 5a Receptor 1 Antagonist

Anya Hammann‐Hänni,Priska Kaufmann,et al.

20222 citations

Efficacy and safety of cotadutide, a dual glucagon‐like peptide‐1 and glucagon receptor agonist, in a randomized phase 2a study of patients with type 2 diabetes and chronic kidney disease

Victoria Parker,Thuong Hoang,et al.

202268 citations

Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037

Emma J. Haagensen,Huw D. Thomas,et al.

20168 citations